We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

175 hedge funds and large institutions have $1.83B invested in Rocket Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 44 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more call options, than puts

Call options by funds: $24.7M | Put options by funds: $7.61M

80% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 44

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

71% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 17

21% more capital invested

Capital invested by funds: $1.52B → $1.83B (+$315M)

16.12% more ownership

Funds ownership: 94.9% → 111.02% (+16%)

7% more funds holding

Funds holding: 164 → 175 (+11)

Holders
175
Holders Change
+11
Holders Change %
+6.71%
% of All Funds
2.78%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.11%
New
29
Increased
79
Reduced
44
Closed
17
Calls
$24.7M
Puts
$7.61M
Net Calls
+$17.1M
Net Calls Change
+$13.5M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$52.4M
2
LGM
Logos Global Management
California
+$31.4M
3
FLSM
Frazier Life Sciences Management
California
+$25.5M
4
ACA
Avoro Capital Advisors
New York
+$22.7M
5
MC
Maverick Capital
Texas
+$22.7M

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$23.8M
2
Goldman Sachs
Goldman Sachs
New York
-$16.6M
3
CAM
Cormorant Asset Management
Massachusetts
-$7.61M
4
PHS
PFM Health Sciences
California
-$4.74M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$362M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$164M +$52.4M +2,880,373 +56%
MC
3
Maverick Capital
Texas
$115M +$22.7M +1,250,000 +29%
BlackRock
4
BlackRock
New York
$105M -$403K -22,180 -0.4%
Vanguard Group
5
Vanguard Group
Pennsylvania
$94.3M +$74.3K +4,085 +0.1%
Westfield Capital Management
6
Westfield Capital Management
Massachusetts
$85.9M +$9.78M +538,209 +15%
State Street
7
State Street
Massachusetts
$64.3M -$709K -39,019 -1%
Citadel Advisors
8
Citadel Advisors
Florida
$54.9M +$1.64M +90,393 +3%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$54.1M +$9.44M +519,145 +25%
LGM
10
Logos Global Management
California
$40.5M +$31.4M +1,725,000 +690%
APM
11
Avidity Partners Management
Texas
$32.5M +$4.75M +261,429 +20%
PA
12
Perceptive Advisors
New York
$31.1M +$6.35M +349,104 +30%
BC
13
Boxer Capital
California
$30M – – –
FLSM
14
Frazier Life Sciences Management
California
$28.7M +$25.5M +1,403,013 New
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$27.4M -$45.2K -2,487 -0.2%
ACA
16
Avoro Capital Advisors
New York
$25.6M +$22.7M +1,250,000 New
Geode Capital Management
17
Geode Capital Management
Massachusetts
$25.4M +$1.02M +56,057 +5%
BAMCO Inc
18
BAMCO Inc
New York
$22.7M +$4.09M +225,231 +26%
CAC
19
Cowen and Company
New York
$22.5M – – –
Millennium Management
20
Millennium Management
New York
$20.6M +$15M +826,592 +461%
NHAS
21
Novo Holdings A/S
Denmark
$20.5M +$1.47M +81,000 +9%
PI
22
Putnam Investments
Massachusetts
$20.5M +$3.68M +202,324 +25%
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$18.5M +$15.9M +874,999 +3,229%
EAM
24
Eventide Asset Management
Massachusetts
$18.4M – – –
Assenagon Asset Management
25
Assenagon Asset Management
Luxembourg
$18M +$8.17M +449,569 +105%
1
2 3 4 5

RCKT Hedge Fund Activity: Q3 2023 in Review

175 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q3 2023, worth a combined $1.83B — up 21% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RCKT positions and 17 closed out — a net gain of 12 holders — while 79 added to existing stakes and 44 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $52.4M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $23.8M sold.

  • 175 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q3 2023, up from 164 in Q2 2023.
  • Funds reported $1.83B of Rocket Pharmaceuticals stock for Q3 2023, up 21% quarter-over-quarter.
  • 29 funds opened new Rocket Pharmaceuticals positions in Q3 2023 and 17 closed out, a net change of +12 holders.
  • The largest Rocket Pharmaceuticals buyer in Q3 2023 was Wellington Management Group, an estimated $52.4M added.
  • The largest Rocket Pharmaceuticals seller in Q3 2023 was Lord, Abbett & Co, an estimated $23.8M sold.

Based on aggregated 13F filings for Q3 2023.